E009: Jenny Barnett: Bringing Precision to the Brain
Jenny Barnett is the founder and CEO of Monument Therapeutics, building precision medicine for psychiatry and neurology.The medicines currently used to treat psychiatric and neurological conditions are often ineffective. Antidepressants taken by 16.7% and 14.2% of the US (CDC-2020) and UK populatio…
Jenny Barnett, CEO and co-Founder of Monument Therapeutics
Measuring brain activity is a challenge in neuroscience. Unlike other medical fields, we can't directly measure the brain. This makes it difficult to develop drugs and determine their effectiveness. Objective measurements are needed to improve treatment decisions for patients.
Improving neuroscienc…
Jenny Barnett, Monument Therapeutics & Five Lives
"Cancer drugs only started working once we realised that we actually had to measure what was going on in the tumour and match them appropriately [to patients]...we're just on the cusp of that approach being accepted in neuroscience."
Jenny Barnett is the CEO of Monument Therapeutics, a Biotech …
Jenny Barnett, CEO, Monument Therapeutics
James chats to Jennifer Barnett, CEO at Monument Therapeutics, a Cambridge Angels portfolio company. We cover Jennifer's career path, the experience of spinning out from Cambridge Cognition, the problem Monument Therapeutics solves, managing a dispersed team, and their plans for the future.
Hoste…
Creating a continuum of supports for student mental wellness with Jenny Barnett
Join SAI Executive Director Lisa Remy as she discusses the mental wellness continuum of supports implemented by the Harlan School District with Superintendent Jenny Barnett. This conversation will not only explore Harlan's successful strategies, but also equip you with valuable tips on finding addi…
Jenny Barnett, Monument Therapeutics & Five Lives
"Cancer drugs only started working once we realised that we actually had to measure what was going on in the tumour and match them appropriately [to patients]...we're just on the cusp of that approach being accepted in neuroscience."
Jenny Barnett is the CEO of Monument Therapeutics, a Biotech …
Innovative approaches to improving drug discovery
This is the latest episode of the free DDW narrated podcast, titled "Innovative approaches to improving drug discovery", which covers three articles written for DDW Volume 24 – Issue 2, Spring 2023 of DDW. They are called: Post-Covid cognitive impairment: a new target for drug development?, Sitti…
LBC RADIO's Jenny Barnett Interviews Charles Linden
Jenni Barnett interviews Charles Linden about anxiety disorder recovery and how he and his organisation have cured hundreds of thousands of people.
Jenny Barnett: New tests and drugs for schizophrenia
Can neuroscience finally catch up with the complexity of mental illness?
Society faces a huge and growing burden from mental illness and impairment. Schizophrenia, for example, is a bigger socioeconomic burden than all cancers put together.
We have medicines for some of these conditions, but typica…
เครื่องมือค้นหาพอดแคสต์
คุณสามารถใช้เว็บไซต์ของเราเพื่อค้นหาพอดแคสต์ของ3,832,342และตอนของ196,985,605ตามบุคคล สถานที่ หรือหัวข้อ
If I have seen further than others, it is by listening to podcasts and standing upon the shoulders of
giants.
‐ Isaac "Llamacorn" Newton
